A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. (Q53189881)
Jump to navigation
Jump to search
scientific article published on 21 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. |
scientific article published on 21 October 2015 |
Statements
1 reference
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. (English)
1 reference
B H O'Neil
1 reference
A J Scott
1 reference
W W Ma
1 reference
S J Cohen
1 reference
L Leichman
1 reference
D L Aisner
1 reference
A R Menter
1 reference
M A Tejani
1 reference
J K Cho
1 reference
J Granfortuna
1 reference
L Coveler
1 reference
O O Olowokure
1 reference
J C Baranda
1 reference
M Cusnir
1 reference
P Phillip
1 reference
J Boles
1 reference
R Nazemzadeh
1 reference
M Rarick
1 reference
D J Cohen
1 reference
J Radford
1 reference
L Fehrenbacher
1 reference
R Bajaj
1 reference
V Bathini
1 reference
P Fanta
1 reference
J Berlin
1 reference
A J McRee
1 reference
R Maguire
1 reference
F Wilhelm
1 reference
M Maniar
1 reference
A Jimeno
1 reference
C L Gomes
1 reference
W A Messersmith
1 reference
21 October 2015
1 reference
1 reference
26
1 reference
2505
1 reference
12
1 reference
Identifiers
1 reference
1 reference